Clinical Research
Through our partnership with Midwest Immunology and Vivo Infusion®, we have a dedicated research department, including physicians, certified nurse coordinators, nurse practitioners, and pharmacists. We collaborate with pharmaceutical companies and local specialists to offer new treatment opportunities and aide in the understanding of multiple sclerosis.
All Case
Nonrelapsing Secondary Progressive Multiple Sclerosis
Relapsing Multiple Sclerosis
Sanofi Study for Relapsing Multiple Sclerosis
Sanofi’s FREXALT Study is looking for people with relapsing forms of multiple sclerosis (RMS) to take part. The purpose of the study is to independently…
Sanofi Study for nrSPMS
Sanofi’s FREVIVA Study is looking for people with non-relapsing secondary progressive multiple sclerosis (nrSPMS) to take part. The goal of this Phase 3 clinical trial…
TG Therapeutics Study for Relapsing Multiple Sclerosis
This 48-week study is to determine the efficacy and safety when switching from your current DMT to ublituximab and to determine if giving it over…
Benefits of Participating in a Clinical Trial
As a patient, clinical trials offer many advantages:
- Learn more about your medical condition
- Have access to new medications that are not yet available to the public
- Receive detailed and thorough medical care for your condition
- You may receive medication and other tests at no costs to you
- You may be compensated for your participation
- Participate in the advancement of medical knowledge
- Contribute to the wellbeing of society
